MRI-Based Liver Iron Content Predicts for Nonrelapse Mortality in MDS and AML Patients Undergoing Allogeneic Stem Cell Transplantation
Martin Wermke(National Center for Tumor Diseases), Uwe Platzbecker(National Center for Tumor Diseases), Gerhard Ehninger(University Hospital Carl Gustav Carus), Martin Bornhäuser(Technische Universität Dresden), Jan Moritz Middeke(Fresenius (Germany)), Michael Laniado(University Hospital Carl Gustav Carus), Igor Theurl(Innsbruck Medical University), Anne Schmidt(Centre National de la Recherche Scientifique), Claudia Schönefeldt(Innsbruck Medical University), Sabine Mair(Innsbruck Medical University), Verena Plodeck(Innsbruck Medical University), Katja Sockel(Innsbruck Medical University), Günter Weiß(Innsbruck Medical University), Malte von Bonin(Städtisches Klinikum Dresden), Johannes Schetelig(University Hospital Carl Gustav Carus)
Cited by 72
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
|Nature Medicine|2013|1k
Macrophage defense mechanisms against intracellular bacteria
|Immunological Reviews|2015|975